GlassScriptPhysician profile
Divya Khurana
NPI 1295039253
$1,472.91
in general payments reported to CMS, 2019-2025
18 companies · $52.56 in 2025
The $52.56 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $36.09 · 2021: $511 · 2022: $530 · 2023: $48.37 · 2024: $195 · 2025: $52.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $256.35 | 2021-2023 | |
| Rhythm Pharmaceuticals, INC. | $199.28 | 2022-2024 | |
| Biomarin Pharmaceutical INC. | $165.00 | 2022 | |
| Novo Nordisk INC | $130.42 | 2021-2025 | Sogroya |
| Tolmar Pharmaceuticals, INC. | $122.77 | 2021 | |
| Dexcom, INC. | $100.16 | 2019 | |
| Amneal Pharmaceuticals LLC | $86.18 | 2021-2022 | |
| Ascendis Pharma Endocrinology INC | $69.55 | 2022 | |
| Sanofi-Aventis U.S. LLC | $64.79 | 2023-2024 | |
| Pfizer INC. | $58.13 | 2021-2022 | |
| Sandoz INC. | $42.21 | 2021-2022 | |
| Lilly USA, LLC | $36.09 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $33.29 | 2021-2022 | |
| Tandem Diabetes Care, INC. | $31.60 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $28.57 | 2025 | Omnipod |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amphastar Pharmaceuticals, INC. | $16.94 | 2023 | Baqsimi |
| Tolmar, INC. | $15.94 | 2024 | |
| Endo Pharmaceuticals INC. | $15.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Divya Khurana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.